Treatment with ivacaftor can lead to weight gain in CF patients with a G551D mutation, a small Australian study shows. Weight gain was significantly related to improvement in fat intake at 16 weeks and younger age at 34 weeks, the open label phase I and phase II study from Westmead Children’s Hospital in Sydney found. ...
Already a member?
Enter your email to keep reading.